Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.
about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationIsolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsHuman cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation.Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses.Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipientsDiagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics.Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infectionClinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitroCytomegalovirus encodes a potent alpha chemokine.High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-upComparison of culture and the antigenemia assay for detection of cytomegalovirus in blood specimens submitted to a reference laboratoryPhysical and chemical methods for enhancing rapid detection of viruses and other agents.Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.Comparison of the CMV brite turbo assay and the digene hybrid capture CMV DNA (Version 2.0) assay for quantitation of cytomegalovirus in renal transplant recipients.Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.Quantitation of cytomegalovirus: methodologic aspects and clinical applications.Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining.Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemiaRapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients.Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry.Identification of human cytomegalovirus strain with immediate-early (IE) antigen-specific monoclonal antibody is prevented by point mutation in IE gene.Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis.Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.Prospective study of cytomegalovirus antigenemia in allograft recipients.Cytomegalovirus antigenemia assay.Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients.Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.Early identification of human cytomegalovirus strains by the shell vial assay is prevented by a novel amino acid substitution in UL123 IE1 gene product.
P2860
Q26826856-8DD3CB20-0FC8-4AD5-BBE4-C38A6BA3B9A7Q33558361-749AF6CA-AF03-4CC7-9472-346B5EC3B2A8Q33662067-13CB7658-8011-4458-BF7F-6AF03BD9CAD6Q33812425-98E62415-E529-482D-97DE-CCBD3D2813F4Q33946557-5A5F8770-8270-44CA-8F00-2EB1FAA286A6Q33963085-5EB14824-6368-4255-89AC-7CF50E18770AQ33966910-3F5F41BB-270A-464E-9646-EE7BCB871B2CQ34102747-916141A2-66E1-4D16-8D8F-B777A3A2415DQ34345137-C402A971-68CC-4F3B-9590-524BCDE35A1DQ34358755-7FB7821E-8990-462F-912D-0C1001D77E08Q34973821-929DADD8-3B3D-415A-83BE-8C2A6C0BC1DCQ35196400-7DC389DE-09AA-4B9E-B17F-F2AE4EBAAEF7Q35525162-E76FED6E-32C9-4369-90AC-160A3B9F26B4Q35901715-B2BE061B-FFC7-4A76-B3C1-F2AC82932ED3Q36436978-F37F4C4E-FFC1-4AFE-A0ED-671B16CAB76AQ36527953-4ECB093F-8028-4370-9974-0EAA0FC7EA4BQ36545212-0110BC0B-5623-45E0-8DF3-1DBFF5BA4BB2Q36639842-D71C7514-69DC-43AC-BACE-361797E96012Q37095025-CB37A061-4D32-4585-BBB5-C09FF3721016Q39461685-4B03907E-A077-4A39-AD61-A3110F17BF77Q39467685-8FC61A63-4770-466F-866B-932FADC20A2EQ39468915-17A280BA-B828-48C3-93D6-99A42D6B29A1Q39552557-DAA8820E-45CF-4796-9D04-5484B567FB50Q39591457-46972C10-C069-4A47-97D3-470246631FC0Q39805887-D72675BF-336A-4E65-98A8-C7F2CDDBBA8DQ40007159-267ABABB-8877-4233-89A0-30AED26D0C7FQ40012406-D16C900E-5EBF-4DBB-8456-BA0D007EBDB7Q40014664-2A0E21AF-754A-4BB2-8A32-CEC33EC869ABQ40178954-455B0C38-0628-4834-B9BD-180F74B4A572Q40180848-461FE920-9CAE-4561-B5EB-870F5BEFEB7DQ40186252-40167014-3B1C-437F-B564-64821F2E2605Q40197928-48BBF2E6-0EE5-468F-8E23-43F636AFF04AQ40211986-CAC689F3-CD6F-435A-91E0-2FFBBF6578A8Q40214631-679CD783-4106-48DF-BBF5-295EBBF498DDQ40214747-C9458135-7657-4048-AF07-F12CB1F6E5FDQ40284739-6E4B7029-B077-4D5D-BF90-54CC904DCDBCQ40339181-63AA8F8D-1657-4797-847C-8012A4F59335Q42940438-B3093DCF-4E47-4A84-92A6-BDB6F1B7843B
P2860
Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Quantification of human cytome ...... s to different viral proteins.
@en
type
label
Quantification of human cytome ...... s to different viral proteins.
@en
prefLabel
Quantification of human cytome ...... s to different viral proteins.
@en
P2093
P2860
P1476
Quantification of human cytome ...... es to different viral proteins
@en
P2093
P2860
P304
P407
P577
1990-12-01T00:00:00Z